Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Bioinformatics for cancer immunology and immunotherapy.

Charoentong P, Angelova M, Efremova M, Gallasch R, Hackl H, Galon J, Trajanoski Z.

Cancer Immunol Immunother. 2012 Nov;61(11):1885-903. doi: 10.1007/s00262-012-1354-x. Epub 2012 Sep 18. Review.

2.

Bioinformatics for cancer immunotherapy target discovery.

Olsen LR, Campos B, Barnkob MS, Winther O, Brusic V, Andersen MH.

Cancer Immunol Immunother. 2014 Dec;63(12):1235-49. doi: 10.1007/s00262-014-1627-7. Epub 2014 Oct 26. Review.

PMID:
25344903
3.

A survey of tools for variant analysis of next-generation genome sequencing data.

Pabinger S, Dander A, Fischer M, Snajder R, Sperk M, Efremova M, Krabichler B, Speicher MR, Zschocke J, Trajanoski Z.

Brief Bioinform. 2014 Mar;15(2):256-78. doi: 10.1093/bib/bbs086. Epub 2013 Jan 21.

4.

Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges.

Srivastava PK, Duan F.

Cancer Immunol Immunother. 2013 May;62(5):967-74. doi: 10.1007/s00262-013-1422-x. Epub 2013 Apr 19. Review.

5.

[Immunotherapy: new insights].

Geissler M, Weth R.

Praxis (Bern 1994). 2002 Dec 18;91(51-52):2236-46. Review. German.

PMID:
12564040
6.

Computational and bioinformatics frameworks for next-generation whole exome and genome sequencing.

Dolled-Filhart MP, Lee M Jr, Ou-Yang CW, Haraksingh RR, Lin JC.

ScientificWorldJournal. 2013;2013:730210. doi: 10.1155/2013/730210. Epub 2013 Jan 13. Review.

7.

Next-generation sequencing in the clinic: promises and challenges.

Xuan J, Yu Y, Qing T, Guo L, Shi L.

Cancer Lett. 2013 Nov 1;340(2):284-95. doi: 10.1016/j.canlet.2012.11.025. Epub 2012 Nov 19. Review.

PMID:
23174106
8.

Recent advances in immunoinformatics: application of in silico tools to drug development.

Evans MC.

Curr Opin Drug Discov Devel. 2008 Mar;11(2):233-41. Review.

PMID:
18283611
9.

Theoretical modeling techniques and their impact on tumor immunology.

Woelke AL, Murgueitio MS, Preissner R.

Clin Dev Immunol. 2010;2010:271794. doi: 10.1155/2010/271794. Epub 2010 Dec 23. Review.

10.

Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction.

Mlecnik B, Sanchez-Cabo F, Charoentong P, Bindea G, Pag├Ęs F, Berger A, Galon J, Trajanoski Z.

BMC Genomics. 2010 Feb 10;11 Suppl 1:S7. doi: 10.1186/1471-2164-11-S1-S7.

11.

Spinning molecular immunology into successful immunotherapy.

Pardoll DM.

Nat Rev Immunol. 2002 Apr;2(4):227-38. Review.

PMID:
12001994
12.

NCI-60 whole exome sequencing and pharmacological CellMiner analyses.

Reinhold WC, Varma S, Sousa F, Sunshine M, Abaan OD, Davis SR, Reinhold SW, Kohn KW, Morris J, Meltzer PS, Doroshow JH, Pommier Y.

PLoS One. 2014 Jul 17;9(7):e101670. doi: 10.1371/journal.pone.0101670. eCollection 2014.

13.

Tracking cellular and immune therapies in cancer.

Kurtz DM, Gambhir SS.

Adv Cancer Res. 2014;124:257-96. doi: 10.1016/B978-0-12-411638-2.00008-2. Review.

PMID:
25287692
14.

Tumor microenvironments, the immune system and cancer survival.

Strausberg RL.

Genome Biol. 2005;6(3):211. Epub 2005 Mar 1. Review.

15.

From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens.

Schultze JL, Vonderheide RH.

Trends Immunol. 2001 Sep;22(9):516-23. Review. Erratum in: Trends Immunol 2001 Oct;22(10):581.

PMID:
11525943
16.

Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.

Liu X, Wang J, Chen L.

Cancer Lett. 2013 Nov 1;340(2):270-6. doi: 10.1016/j.canlet.2012.11.002. Epub 2012 Nov 12. Review.

PMID:
23153794
17.

Bioinformatics for study of autoimmunity.

Petrovsky N, Brusic V.

Autoimmunity. 2006 Dec;39(8):635-43. Review.

PMID:
17178560
18.

Tumor neoantigens: building a framework for personalized cancer immunotherapy.

Gubin MM, Artyomov MN, Mardis ER, Schreiber RD.

J Clin Invest. 2015 Sep;125(9):3413-21. doi: 10.1172/JCI80008. Epub 2015 Aug 10. Review.

PMID:
26258412
19.

Immunology in tumor therapeutics: an overview.

Barber HR.

Del Med J. 1980 Apr;52(4):197-209. Review. No abstract available.

PMID:
6153996
20.

Immunoinformatics and modeling perspective of T cell epitope-based cancer immunotherapy: a holistic picture.

Mishra S, Sinha S.

J Biomol Struct Dyn. 2009 Dec;27(3):293-306. Review.

PMID:
19795913
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk